• LAST PRICE
    1.4000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.3500/ 1
  • Ask / Lots
    1.4500/ 5
  • Open / Previous Close
    1.4500 / 1.4000
  • Day Range
    Low 1.3700
    High 1.4851
  • 52 Week Range
    Low 0.7600
    High 4.4199
  • Volume
    95,131
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.48
TimeVolumeEDSA
09:32 ET7811.4851
09:35 ET1001.46
09:37 ET1001.46
09:39 ET9501.479
09:42 ET1001.45
09:44 ET11001.4501
09:46 ET1001.45
09:48 ET9001.4503
09:50 ET1001.45
09:51 ET10001.469
09:53 ET1001.45
09:55 ET1001.45
09:57 ET1001.45
10:00 ET1001.45
10:04 ET1001.45
10:06 ET5481.45
10:08 ET7801.45
10:09 ET1001.45
10:11 ET1001.45
10:13 ET1001.45
10:15 ET1001.45
10:18 ET1001.45
10:20 ET1001.45
10:22 ET1001.45
10:24 ET1001.45
10:26 ET12011.45
10:27 ET1001.44
10:29 ET7001.44
10:33 ET2001.44
10:36 ET1001.44
10:38 ET2001.44
10:40 ET1001.44
10:42 ET1001.44
10:45 ET8851.44
10:47 ET10501.42
10:49 ET1001.42
10:51 ET1001.42
10:56 ET2001.42
10:58 ET1001.42
11:00 ET1001.42
11:02 ET1001.42
11:03 ET1001.42
11:05 ET1001.43
11:07 ET1001.43
11:09 ET1001.43
11:12 ET1001.43
11:16 ET1001.43
11:18 ET1001.43
11:20 ET23001.444
11:25 ET8751.4781
11:30 ET2001.45
11:32 ET1001.45
11:36 ET1001.45
11:38 ET9741.45
11:39 ET1001.45
11:41 ET1001.45
11:45 ET2001.45
11:48 ET1001.45
11:50 ET1001.45
11:52 ET1001.45
11:54 ET1001.45
11:56 ET1001.45
11:57 ET1001.45
11:59 ET1001.45
12:01 ET2001.45
12:06 ET1001.45
12:08 ET1001.45
12:10 ET1001.45
12:12 ET2001.45
12:14 ET4251.43
12:15 ET1001.44
12:17 ET1001.44
12:19 ET2001.44
12:21 ET1001.44
12:24 ET4151.43
12:28 ET1001.43
12:30 ET3001.43
12:32 ET1001.43
12:33 ET1001.43
12:37 ET2001.43
12:44 ET18001.43
12:46 ET2001.42
12:48 ET47291.425
12:50 ET1001.42
12:51 ET2001.422
12:53 ET2001.425
12:55 ET2001.42
12:57 ET2001.42
01:00 ET1001.42
01:02 ET1001.42
01:04 ET2001.42
01:06 ET14691.42
01:08 ET11351.42
01:09 ET1001.4127
01:15 ET20001.429
01:22 ET1001.42
01:24 ET1001.42
01:27 ET1001.41
01:29 ET3001.41
01:31 ET1001.41
01:33 ET1001.41
01:36 ET3001.41
01:38 ET5441.41
01:42 ET2001.41
01:44 ET1001.41
01:45 ET2001.41
01:47 ET1001.41
01:49 ET1001.41
01:51 ET1001.41
01:54 ET3001.41
01:56 ET1001.41
01:58 ET22001.41
02:02 ET2001.41
02:03 ET2001.41
02:05 ET1001.41
02:09 ET3001.41
02:12 ET1001.41
02:14 ET1001.41
02:16 ET2001.41
02:18 ET3501.41
02:20 ET2001.41
02:21 ET30261.4114
02:23 ET1001.41
02:25 ET1001.41
02:27 ET3001.41
02:30 ET1001.41
02:32 ET1001.41
02:34 ET1001.41
02:36 ET3001.41
02:39 ET2001.41
02:41 ET1001.41
02:43 ET2001.41
02:45 ET2001.41
02:48 ET2001.41
02:50 ET1001.41
02:52 ET1001.41
02:54 ET2001.41
02:56 ET2001.41
02:57 ET54871.41
03:01 ET2901.4
03:03 ET79361.4
03:06 ET1001.4
03:08 ET1001.4
03:10 ET3001.4
03:12 ET1001.4
03:14 ET47211.4
03:15 ET19871.39
03:17 ET2001.38
03:19 ET26001.37
03:21 ET1121.37
03:24 ET1001.37
03:26 ET9101.38
03:28 ET1001.37
03:30 ET1001.38
03:32 ET1001.38
03:33 ET1001.38
03:35 ET7001.38
03:37 ET2001.37
03:42 ET2001.37
03:44 ET2001.37
03:46 ET3001.37
03:48 ET1001.37
03:50 ET2001.37
03:51 ET3001.38
03:53 ET2001.38
03:55 ET1001.38
03:57 ET7001.3831
04:00 ET86421.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEDSA
Edesa Biotech Inc
28.6M
-1.2x
---
United StatesLSTA
Lisata Therapeutics Inc
28.7M
-0.3x
---
United StatesADXN
Addex Therapeutics Ltd
25.9M
0.0x
---
United StatesGWLL
Goldenwell Biotech Inc
28.3M
-286.4x
---
United StatesSTSA
Satsuma Pharmaceuticals Inc
29.3M
-0.4x
---
United StatesAGE
AgeX Therapeutics Inc
28.4M
-2.9x
---
As of 2023-02-07

Company Information

Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on inflammatory and immune-related diseases. The Company's two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy, developing as a treatment for acute respiratory distress syndrome (ARDS), a life-threatening form of respiratory failure. ARDS can be caused by viral diseases, including Covid-19, bacterial pneumonia, sepsis, chest injury and other causes. Specifically, EB05 inhibits toll-like receptor 4 (TLR4), an immune signaling protein and an important mediator of inflammation that has been shown to be activated by SARS-COV2 as well as other respiratory infections, such as influenza. In addition to EB05, the Company is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness.

Contact Information

Headquarters
100 Spy CrtMARKHAM, ON, Canada L3R 5H6
Phone
905-475-1234
Fax
905-475-1234

Executives

Independent Chairman of the Board
Sean Macdonald
President
Michael Brooks
Chief Executive Officer, Corporate Secretary and Director
Pardeep Nijhawan
Chief Financial Officer
Kathi Niffenegger
Director
Jennifer Chao

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$28.6M
Revenue (TTM)
$0.00
Shares Outstanding
19.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.46
EPS
$-1.20
Book Value
$0.56
P/E Ratio
-1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.